Device Trial Radar · NCT00730834
Customized Acoustic Stimulation for Long Term Medical Benefit for the Relief of Tinnitus and Hyperacusis
Last checked: Nov 19, 2026Latest source record: Aug 25, 2009 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Status unknown
Enrollment
53
Actual
Start
Jun 2007
Primary completion
Dec 2010
Study completion Dec 2010
Sponsor
- Lead sponsor
- Neuromonics, Inc.Not on our public-company list
- Sponsor type
- Industry
- First posted
- Aug 8, 2008
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Non randomized
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
Neuromonics TInnitus Treatment CALM study is a multi site study of 100 adult subjects with clinically significant disturbing tinnitus to evaluate outcome measures using the FDA cleared Neuromonics treatment after 6, 12, 24 and 36 months. Patients must be meet certain inclusion criteria and they are also required to pay for the all costs of the treatment. Subjects will be provided a modest participation fee at 6, 12, 24 and 36 months upon completion of patient questionnaires (subjects must have access to a computer and internet in order to complete on line questionnaires).
Conditions
- Tinnitus
- Hyperacusis
Interventions
OasisDevice
Digital sound player that provides customized acoustic stimulus based on subjects hearing thresholds
Primary outcomes
What the sponsor says the trial is designed to measure.
- Pre and post treatment scores on Tinnitus reaction questionnaireTime frame: 6, 12, 24, 36 months
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Silverstein Ear Institute
Sarasota, Florida
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.